What are the most common primary cancers that metastasize to the choroid?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 16, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Most Common Cancers Causing Choroidal Metastases

Breast cancer (40-47%) and lung cancer (21-29%) are the two most common primary malignancies that metastasize to the choroid, with breast cancer being the leading cause overall. 1

Primary Cancer Distribution

The choroid is the most common site for intraocular metastatic disease due to its rich vascular supply. The hierarchy of primary cancers causing choroidal metastases is well-established:

  • Breast cancer: 40-47% of all choroidal metastases 1, with a notable finding that 53% of patients in one series had breast cancer as the primary 2
  • Lung cancer: 21-29% of cases 1, representing 26-53% in various series 2, 3
  • Other primaries (much less common): kidney, gastrointestinal tract, melanoma, thyroid, prostate, cervical, and ovarian cancers 2

Key Clinical Patterns to Recognize

Gender-Specific Considerations

  • Women: Breast carcinoma is the most common primary
  • Men: Lung cancer is the most common primary 4

Laterality and Multiplicity Patterns

These patterns help identify the likely primary source:

  • Bilateral, multifocal metastases: Most often secondary to breast cancer 1, 3
  • Unilateral, unifocal metastasis: More commonly associated with lung cancer 5, 1

Temporal Presentation

The timing of choroidal metastasis differs significantly by primary tumor:

  • Lung cancer: Mean interval of 9 months after primary diagnosis; choroidal metastasis is the first clinical sign of tumor disease in 58% of patients 2
  • Breast cancer: Mean interval of 68 months (over 5 years) after primary diagnosis; choroidal metastasis is the first sign of metastatic disease in 28% of patients 2

Critical Clinical Pitfall

In 18% of patients presenting with choroidal metastasis, there is no prior history of cancer 2. In these cases, lung cancer is the most likely culprit—12 of 13 patients without known cancer history were diagnosed with lung cancer upon workup. This underscores the importance of comprehensive systemic evaluation when choroidal metastasis is identified, even without known malignancy.

Lung Cancer Subtype Specificity

While adenocarcinoma is the primary lung cancer subtype associated with choroidal metastasis, small cell lung cancer (SCLC) rarely involves the choroid 5. When SCLC does metastasize to the choroid, it typically presents as unilateral lesions.

Systemic Disease Implications

Choroidal metastasis indicates widespread systemic disease in 96% of patients 2. This finding serves as a red flag for extensive metastatic burden and necessitates comprehensive staging, including chest CT, abdominal CT, and bone scintigraphy to identify additional metastatic sites.

References

Research

Choroidal metastases: origin, features, and therapy.

Indian journal of ophthalmology, 2015

Research

[Clinical characteristics of choroidal metastasis].

Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft, 2003

Research

Treatment options for metastatic tumors to the choroid.

Seminars in ophthalmology, 2005

Research

Unilateral choroidal metastases as an unusual presentation of small cell lung cancer.

Proceedings (Baylor University. Medical Center), 2024

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.